Iprodione MarketSize, Share & Industry Analysis, 2026-2034By FormulationBy Crop TypeBy ApplicationBy Distribution ChannelBy Mode of Application
Full title & scope — all 5 axes with their segments
Iprodione Market Size, Share & Industry Analysis, By Formulation (SC, WP, EC, WG), By Crop Type (Horticultural, Agricultural), By Application (Fruits, Vegetables), By Distribution Channel (Distributors, Agricultural supply stores, Direct sales, Online retailers), By Mode of Application (Foliar Spray, Soil Treatment, Seed Treatment), and Regional Forecast, 2026-2034
Segment definitions and share of revenue by product, animal, end user and region.
- 01By FormulationSC · WP · EC
- 02By Crop TypeHorticultural · Agricultural
- 03By ApplicationFruits · Vegetables
- 04By Distribution ChannelDistributors · Agricultural supply stores · Direct sales
- 05By Mode of ApplicationFoliar Spray · Soil Treatment · Seed Treatment
- 06By Region
Market Analysis & Outlook
Iprodione is a dicarboximide fungicide formulated as suspension concentrates, wettable powders, emulsifiable concentrates and water dispersible granules, applied to control botrytis, sclerotinia and related fungal diseases on fruit, vegetable and other high-value horticultural crops. It is bought primarily by commercial growers, grower cooperatives and agricultural input distributors who select a formulation and application method to fit a specific crop, growth stage and disease pressure. Use spans field application ahead of harvest through post-harvest and nursery treatment, wherever a labeled crop faces recurring fungal pressure.
Growth of 5% a year carries the global iprodione market from USD 320 million in 2025 to USD 499.4 million in 2034. The full series behind that rate covers USD 259.4 million in 2020, USD 306.8 million in 2024, USD 338 million in 2026 and USD 410.8 million in 2030, with 2025 as the base year.
On the formulation axis, growth rates run from 0.25% for EC up to 8.93% for WG. SC carries the volume: USD 121.6 million and 38% of revenue in 2025, USD 199.8 million and 40.01% in 2034. The lines gaining share are SC and WG. WP and EC lose share without losing revenue.
By crop type, Horticultural accounts for 62% of 2025 revenue at USD 198.4 million, reaching USD 324.6 million and 65% by 2034. It is also the fastest-growing line on this axis at 5.62%, so the split concentrates over the period instead of balancing. This axis divides the same revenue as the formulation split instead of adding to it, so the two are read together and never summed.
Asia Pacific is the largest region at 36.86% of 2025 revenue, worth USD 117.9 million and reaching USD 209.7 million by 2034. Europe follows at 22.07%, moving from USD 70.6 million to USD 74.9 million, and Middle East and Africa is the smallest at 6.36%. Because Asia Pacific, Latin America and Middle East and Africa take share, the revenue added by 2034 concentrates instead of spreading across all five regions.
The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, four formulation lines and five segmentation axes across a fifteen-year window.
Market Size, 2020–2034
USD MillionRevenue in USD Million. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- Revenue grows from USD 320 million in 2025 to USD 499.4 million in 2034, a compound annual rate of 5%, having reached USD 306.8 million in 2024 from USD 259.4 million in 2020.
- SC is the largest formulation line at USD 121.6 million in 2025, a 38% share, reaching USD 199.8 million and 40.01% of revenue by 2034.
- WG is the fastest-growing line at 8.93%, lifting its share from 20% in 2025 to 27.99% in 2034 and its revenue from USD 64 million to USD 139.8 million.
- The bull case puts 2034 revenue at USD 540.7 million and the bear case at USD 461.3 million, either side of the USD 499.4 million base case, each with its own stated assumption in the full report.
- 36.86% of 2025 revenue is generated in Asia Pacific, worth USD 117.9 million and rising to USD 209.7 million by 2034; Middle East and Africa is smallest at 6.36%.
- Within Asia Pacific, China is the worked country example, at USD 56.6 million in 2025; 48% of regional revenue in the base year, and USD 100.7 million by 2034.
- Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region, not as a single blended series.
Market Trends
Revenue Share, By by formulation
Base year 2025SC leads with 38.0% of by formulation segment revenue.
Share of by formulation segment revenue, most recent base year.
The global iprodione market is shaped over 2026-2034 by three measurable movements: a change in the formulation mix, a shift in where revenue sits geographically, and the 5% rate carrying the total.
None of them reverses the market's direction. Every line and every region grows in absolute terms across the period; the movement is in which of them captures the revenue added.
WG outpaces EC. Between 2026 and 2034, 8.93% growth in WG against 0.25% in EC pulls the formulation mix apart. By 2034 the two sit at 27.99% and 9.99% of revenue, against 20% and 15% in 2025. Neither contracts: USD 64 million becomes USD 139.8 million, USD 48 million becomes USD 49.9 million. What the spread decides is which of them a supplier's revenue is exposed to.
Asia Pacific, Latin America and Middle East and Africa gain regional share. Asia Pacific moves from 36.86% of revenue in 2025 to 42% in 2034, worth USD 117.9 million rising to USD 209.7 million; Latin America moves from 16.14% of revenue in 2025 to 20% in 2034, worth USD 51.6 million rising to USD 99.9 million; Middle East and Africa moves from 6.36% of revenue in 2025 to 7% in 2034, worth USD 20.4 million rising to USD 35 million. Against that, North America at 18.57% moving to 16%, Europe at 22.07% moving to 15%, a fall in share, not in revenue. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.
A continuation, not an inflection. The market moves through USD 259.4 million in 2020, USD 306.8 million in 2024, USD 320 million in 2025, USD 338 million in 2026, USD 410.8 million in 2030 and USD 499.4 million in 2034. No year breaks the trajectory, and the 5% forecast rate compares with 4.29% recorded over 2020-2025, a continuation, not an inflection. That moves the planning question away from timing a turn and onto the formulation and regional mixes, where the actual movement is.
Market Growth Factors
WG carries the market's growth rate
Market Drivers
3- 01WG carries the market's growth rate
The fastest line on the formulation axis is WG, at 8.93% against the market's 5%, taking USD 64 million to USD 139.8 million and 20% of revenue to 27.99%. The market's overall 5% depends on that rate holding: at the 0.25% recorded by EC, the same revenue base would compound to a materially smaller 2034 total. Exposure to this line, not to the market as a whole, is what determines a supplier's own rate.
- 02Asia Pacific carries 36.86% of the base and keeps growing
Asia Pacific is the largest region at USD 117.9 million in 2025, 36.86% of global revenue, and reaches USD 209.7 million by 2034 on a share rising to 42%. Behind it, Europe holds 22.07%; USD 70.6 million rising to USD 74.9 million. Because both the existing revenue and the revenue added concentrate in these two, regional weighting matters more to a forecast than regional count does.
- 03A demonstrated trajectory, not a projected turnaround
Revenue rose through USD 259.4 million in 2020, USD 306.8 million in 2024 and USD 320 million in 2025, a compound 4.29% across the historical period. The forecast continues at 5% to USD 499.4 million in 2034. Because the growth is already in the record and not only in the projection, the rate is held flat across the forecast instead of ramped, and the risk in the number sits in the mix assumptions, not in whether the market grows at all.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Sustained fungal disease pressure on fruit and vegetable crops | High | +70 | High | High | Medium |
| 2 | Expanding fruit and vegetable cultivation area in Asia Pacific and Latin America | High | +55 | Medium | High | High |
| 3 | Shift toward water dispersible granule and suspension concentrate formulations | Medium-High | +30 | Medium | Medium | High |
| 4 | Widening distributor and online-retail reach into underserved growing regions | Medium | +20 | Low | Medium | Medium |
| 5 | Generic manufacturer capacity expansion in China and India | Medium | +18 | Medium | Medium | Low |
| 6 | Others | Low | +8.4 | Low | Low | Low |
| Total | +201.4 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | European Union non-renewal and use restrictions on iprodione | High | −15 | High | High | Medium |
| 2 | Grower shift toward newer single-site fungicide chemistries | Medium | −7 | Low | Medium | Medium |
| Total | −22 | |||||
Drivers contribute 201.4 Million and restraints remove 22 Million, a net 179.4 Million, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
The 5% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the formulation axis, and where regional growth is concentrated.
Restraining Factors
Downside case: USD 461.3 million by 2034, against USD 499.4 million in the base case
Market Restraints
2- 01Downside case: USD 461.3 million by 2034, against USD 499.4 million in the base case
Bear assumes the European Union's restriction tightens further and effectively spreads to additional markets, and that growers substitute toward newer single-site fungicide chemistries faster than the base case expects. On that assumption 2034 revenue lands at USD 461.3 million against the USD 499.4 million base case, from the same USD 320 million 2025 starting point.
- 02WP grows below the market rate
WP carries 27% of 2025 revenue at USD 86.4 million but compounds at 2.61% against 5% for the market, taking its share to 22.01% by 2034 even as revenue rises to USD 109.9 million. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.
Market Opportunities
Upside case: USD 540.7 million by 2034
Market Opportunities
2- 01Upside case: USD 540.7 million by 2034
Bull assumes Asia Pacific and Latin America cultivation area expands faster than the base case and that no additional major market follows the European Union in restricting iprodione use. On that assumption the market reaches USD 540.7 million by 2034 against USD 499.4 million in the base case, from the same USD 320 million in 2025.
- 02WG is where share changes hands
WG grows at 8.93% against 5% for the market, adding revenue from USD 64 million in 2025 to USD 139.8 million in 2034 and taking its share from 20% to 27.99%. It is the place on this axis where share changes hands at scale, so it is where an entrant can take position without displacing the incumbent in SC.
Market Challenges
Revenue is concentrated in SC
Market Challenges
2- 01Revenue is concentrated in SC
With 38% of 2025 revenue and 40.01% of 2034 revenue (USD 121.6 million rising to USD 199.8 million) SC is where the market's exposure sits. Anything that changes demand for it changes the headline number; nothing else on the axis carries that weight.
- 02China is 48% of Asia Pacific
48% of the leading region is one country: China, at USD 56.6 million against Asia Pacific's USD 117.9 million in 2025, and USD 100.7 million by 2034. A regional number that depends this heavily on one country carries that country's specific conditions inside it, which a reader treating the region as diversified would miss.
Segmentation Analysis
5 axesSegmentation runs along five axes: formulation, crop type, application, distribution channel and mode of application. Each axis cuts the same total revenue along a different commercial dimension, so the splits are alternative views of one market, not additions to it.
All four formulation lines expand in revenue terms over the forecast period. Share is the dividing line; two take it, the others cede it.
By Formulation · 4 segments
SC Led by Formulation in 2025, with WG Growing Fastest
- Largest SC · 38%
- Fastest WG · 8.9%
- Moves most WG · +8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| SC | $122M | 38% | $200M | 40%+2 | 5.6% |
| WP | $86.40M | 27% | $110M | 22%-5 | 2.6% |
| EC | $48M | 15% | $49.90M | 10%-5 | 0.3% |
| WG | $64M | 20% | $140M | 28%+8 | 8.9% |
Suspension concentrate formulations lead because they combine straightforward mixing with strong deposition on fruit and vegetable canopies, a balance most applicators already trust. Water dispersible granules are gaining fastest as growers and distributors favor lower-solvent, easier-to-transport packaging that reduces handling risk, while emulsifiable concentrates lose ground under tightening solvent and worker-exposure rules in several regions. The order does not change: SC is still largest in 2034, and what moves is how much it holds. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.
By Crop Type · 2 segments
Horticultural Both Leads the Crop type Axis and Grows Fastest on It
- Largest Horticultural · 62%
- Fastest Horticultural · 5.6%
- Moves most Horticultural · +3 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Horticultural | $198M | 62% | $325M | 65%+3 | 5.6% |
| Agricultural | $122M | 38% | $175M | 35%-3 | 3.9% |
Horticultural use leads because iprodione is applied mainly on high-value crops such as grapes, strawberries and other fruiting plants where fungal disease control protects yield quality that buyers pay a premium for. Horticultural demand is also growing fastest as intensive fruit and vegetable production expands across Asia Pacific and Latin America, outpacing the slower, more price-sensitive agricultural row-crop segment. By 2034 Horticultural is still ahead, making this a shift in weight, not a change of leader.
By Application · 2 segments
Fruits Both Leads the Application Axis and Grows Fastest on It
- Largest Fruits · 55%
- Fastest Fruits · 5.5%
- Moves most Fruits · +2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Fruits | $176M | 55% | $285M | 57%+2 | 5.5% |
| Vegetables | $144M | 45% | $215M | 43%-2 | 4.4% |
Fruit crops lead consumption because grapes, berries and stone fruit carry a long history of dicarboximide fungicide use against botrytis and related rots, and growers of these crops tolerate higher per-hectare treatment costs to protect saleable quality. Fruit demand is also growing faster than vegetables as orchard and vineyard acreage expands in emerging producing regions, while vegetable growers increasingly rotate toward newer fungicide chemistries. By 2034 Fruits is still ahead, making this a shift in weight, not a change of leader.
By Distribution Channel · 4 segments
Online retailers Outpaces the Axis While Distributors Holds the Largest Share
- Largest Distributors · 42%
- Fastest Online retailers · 14.5%
- Moves most Online retailers · +8 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Distributors | $134M | 42% | $190M | 38%-4 | 3.7% |
| Agricultural supply stores | $96M | 30% | $135M | 27%-3 | 3.6% |
| Direct sales | $64M | 20% | $94.90M | 19%-1 | 4.3% |
| Online retailers | $25.60M | 8% | $79.90M | 16%+8 | 14.5% |
Distributors lead because most growers, especially smallholders, rely on local intermediaries who bundle credit, technical advice and last-mile delivery that a single manufacturer cannot easily replicate. Online retail is growing fastest as larger commercial farms and cooperatives in Asia Pacific begin ordering registered crop protection products directly through digital platforms offering price transparency and faster reordering than a traditional store visit. Distributors remains the largest line through 2034, so the axis changes in proportion, not in order.
By Mode of Application · 3 segments
Foliar Spray Held the Dominant Share of the Mode of application Segment in 2025
- Largest Foliar Spray · 72%
- Fastest Seed Treatment · 6.3%
- Moves most Foliar Spray · -2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Foliar Spray | $230M | 72% | $350M | 70%-2 | 4.6% |
| Soil Treatment | $57.60M | 18% | $94.90M | 19%+1 | 5.7% |
| Seed Treatment | $32M | 10% | $54.90M | 11%+1 | 6.3% |
Foliar spray leads because iprodione controls diseases that attack leaves, flowers and fruit surfaces directly, and spraying remains the only practical way to reach those plant parts at the timing disease pressure demands. Soil treatment is growing fastest as growers add it against soil-borne pathogens in high-value horticultural rotations, a smaller but expanding use case next to the already mature, broadly adopted spray segment. The order does not change: Foliar Spray is still largest in 2034, and what moves is how much it holds.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The 3rd-largest region covered — 2.6 points of share move elsewhere by 2034.
- Rank 3 of 5
- 2025 share 18.6%
- By 2034 16%
- Revenue $59.40M → $79.90M
In North America, 18.57% of global revenue puts 2025 at USD 59.4 million and reaches USD 79.9 million by 2034. Among the five regions it ranks third by revenue in both years.
By 2034 the share stands at 16%, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
The formulation mix reported at global level applies here, with SC the largest line at 38% of 2025 revenue and WG the fastest-growing at 8.93%. Per-axis and per-country detail for North America sits in the full report.
United States
Sets the pace for North America at 78% of it, growing 1.3×.
- In region 1 of 2
- Of region 78%
- Of global 14.5%
- Revenue $46.30M → $62.30M
The largest single market in North America is the United States, at USD 46.3 million in 2025 and USD 62.3 million in 2034. Carrying 78% of the region in the base year, it sets North America's direction instead of merely contributing to it. The region itself runs USD 59.4 million to USD 79.9 million over the same period, and this is the market carrying the country-level detail in the full report.
Composition here matches the global split: the largest line is SC at 38% of 2025 revenue, easing to 40.01% by 2034, and the fastest is WG at 8.93%, from 20% to 27.99%. Because the country carries 78% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by formulation for the United States is reported separately in the full report.
The Environmental Protection Agency governs iprodione in the United States as a conventional agricultural fungicide under the Federal Insecticide, Fungicide, and Rodenticide Act. A supplier must hold an EPA product registration before the fungicide can be sold or distributed, supported by data on toxicology, environmental fate, and residue behavior. Tolerances for residues on treated crops are established under the Federal Food, Drug, and Cosmetic Act and enforced by the Food and Drug Administration and the Department of Agriculture at the point of sale. Labelling must carry EPA-approved directions for use, restricted-entry intervals, and hazard statements, and any formulation change or new use pattern requires an amended registration before it can reach the market.
Competition in the United States runs between the suppliers this study tracks: Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG. Two different problems sit on the same axis: holding SC at 38% of 2025 revenue, and taking WG while it grows at 8.93%. Per-company positioning and share at country level are in the full report only.
Canada
2nd-largest in North America, growing 1.3×.
- In region 2 of 2
- Of region 22%
- Of global 4.1%
- Revenue $13.10M → $17.60M
Canada is sized at USD 13.1 million in 2025, rising to USD 17.6 million by 2034; 4.1% of global revenue and 22% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 2nd-largest region covered, and the one giving up the most — 7.1 points of share move elsewhere by 2034.
- Rank 2 of 5
- 2025 share 22.1%
- By 2034 15%
- Revenue $70.60M → $74.90M
In Europe, 22.07% of global revenue puts 2025 at USD 70.6 million and reaches USD 74.9 million by 2034. Among the five regions it ranks second by revenue in both years.
Share settles at 15% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
SC leads here as it does globally, at 38% of 2025 revenue, and WG again grows fastest at 8.93%. Europe is reported axis by axis and country by country in the full study.
France
The largest market in Europe, growing 1.1×.
- In region 1 of 2
- Of region 32%
- Of global 7.1%
- Revenue $22.60M → $24M
32% of Europe's base-year revenue comes from France; USD 22.6 million, rising to USD 24 million by 2034. Its 32% of base-year regional revenue leads the region, though enough sits elsewhere that Europe is not a proxy for it. Set against USD 70.6 million and USD 74.9 million for the region, it is why this market, and not a smaller one, is the one reported in full.
The formulation pattern in France is the global one: 38% of 2025 revenue in SC, 40.01% by 2034, against 8.93% growth in WG taking it from 20% to 27.99%. Since 32% of Europe's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-formulation revenue for France appears on its own in the full report.
France applies the European Union's Plant Protection Products Regulation to iprodione, with technical review coordinated through the European Food Safety Authority and national implementation carried out by ANSES, the food and environmental safety agency responsible for approving products for the French market. Iprodione's own approval as an active substance was not renewed at EU level on toxicological grounds, so it can no longer be sold or applied to crops grown in France, and any residual authorisations have lapsed. Produce entering French and wider EU markets is instead checked against maximum residue limits set under EU food law, with enforcement falling to national food safety inspectors, a separate mechanism from the plant protection approval route itself.
The suppliers tracked in this study (Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG) compete in France across the formulation lines above. Volume sits in SC at 38% of 2025 revenue; movement sits in WG at 8.93% growth. The commercial size of that position is USD 70.6 million in 2025 and USD 74.9 million by 2034, 22.07% of the global total in the base year.
Spain
2nd-largest in Europe, growing 1.1×.
- In region 2 of 2
- Of region 26%
- Of global 5.8%
- Revenue $18.40M → $19.50M
Spain is sized at USD 18.4 million in 2025, rising to USD 19.5 million by 2034; 5.8% of global revenue and 26% of Europe. It is reported separately from France across every segmentation axis in the full report.
Asia Pacific Market Analysis
The largest region covered — it picks up 5.1 points of share by 2034, while revenue still grows 1.8×.
- Rank 1 of 5
- 2025 share 36.9%
- By 2034 42%
- Revenue $118M → $210M
36.86% of the global iprodione market sits in Asia Pacific in 2025, worth USD 117.9 million on the way to USD 209.7 million by 2034. It is a dominant region on this axis, first by revenue throughout the period.
Share climbs to 42% by 2034, because it outgrows the market's 5%; the revenue added here is disproportionate to where the region started.
Within the region the formulation split tracks the global one; 38% of 2025 revenue in SC, fastest growth of 8.93% in WG. The full report breaks Asia Pacific out along every axis and by country.
China
The largest market in Asia Pacific, growing 1.8×.
- In region 1 of 2
- Of region 48%
- Of global 17.7%
- Revenue $56.60M → $101M
48% of Asia Pacific's base-year revenue comes from China; USD 56.6 million, rising to USD 100.7 million by 2034. Its 48% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. The region itself runs USD 117.9 million to USD 209.7 million over the same period, and this is the market carrying the country-level detail in the full report.
Composition here matches the global split: the largest line is SC at 38% of 2025 revenue, easing to 40.01% by 2034, and the fastest is WG at 8.93%, from 20% to 27.99%. Its 48% weight in Asia Pacific means those movements carry straight into the regional totals. The full report reports China by formulation separately.
In China, iprodione falls under the pesticide registration system administered by the Ministry of Agriculture and Rural Affairs, with technical evaluation carried out by the Institute for the Control of Agrochemicals. A supplier must obtain a pesticide registration certificate before manufacture or sale, supported by efficacy, toxicology, and residue trial data specific to the crops and application patterns proposed. Formulations are also subject to national pesticide product standards covering packaging and labelling content, which must state approved crop uses, dosage instructions, and safety precautions in Chinese. Import of technical material or formulated product additionally requires clearance under China's agrochemical import licensing rules before customs release is granted.
Competition in China runs between the suppliers this study tracks: Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG. Two different problems sit on the same axis: holding SC at 38% of 2025 revenue, and taking WG while it grows at 8.93%. A supplier weighted toward Asia Pacific is competing over a base of USD 117.9 million in 2025 reaching USD 209.7 million by 2034, 36.86% of global revenue at the start of that period.
India
2nd-largest in Asia Pacific, growing 1.8×.
- In region 2 of 2
- Of region 28%
- Of global 10.3%
- Revenue $33M → $58.70M
India is sized at USD 33 million in 2025, rising to USD 58.7 million by 2034; 10.3% of global revenue and 28% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Latin America Market Analysis
The 4th-largest region covered — it picks up 3.9 points of share by 2034, while revenue still grows 1.9×.
- Rank 4 of 5
- 2025 share 16.1%
- By 2034 20%
- Revenue $51.60M → $99.90M
USD 51.6 million of 2025 revenue is generated in Latin America, 16.14% of the global iprodione market with USD 99.9 million projected for 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.
By 2034 the share has moved up to 20%, because it outgrows the market's 5%; the revenue added here is disproportionate to where the region started.
The formulation mix reported at global level applies here, with SC the largest line at 38% of 2025 revenue and WG the fastest-growing at 8.93%. Per-axis and per-country detail for Latin America sits in the full report.
Brazil
Sets the pace for Latin America at 62% of it, growing 1.9×.
- In region 1 of 2
- Of region 62%
- Of global 10%
- Revenue $32M → $61.90M
Brazil is the largest market within Latin America, generating USD 32 million in 2025 and projected to reach USD 61.9 million by 2034. Carrying 62% of the region in the base year, it sets Latin America's direction instead of merely contributing to it. Regional revenue of USD 51.6 million in 2025 and USD 99.9 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Brazil buys along the same lines as the market globally; SC first at 38% of 2025 revenue and 40.01% in 2034, WG fastest at 8.93% on a share moving from 20% to 27.99%. Its 62% weight in Latin America means those movements carry straight into the regional totals. Per-formulation revenue for Brazil appears on its own in the full report.
Brazil regulates iprodione through a shared registration system involving three federal bodies: the Ministry of Agriculture, Livestock and Supply evaluates agronomic efficacy, the health regulator ANVISA assesses toxicology and sets residue limits, and the environmental agency IBAMA reviews ecological hazard before an agrochemical registration is granted. A supplier needs approval from all three before the product can be marketed, and the registration specifies the crops, application rates, and safety intervals for which use is permitted. Labels must carry the hazard classification assigned under Brazilian pesticide law, along with re-entry and pre-harvest interval instructions, and any change to formulation or claimed use triggers a fresh review by the relevant agency.
Competition in Brazil runs between the suppliers this study tracks: Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG. The commercially relevant division is 38% of 2025 revenue in SC, where the volume is, against 8.93% growth in WG, where share moves. A supplier weighted toward Latin America is competing over a base of USD 51.6 million in 2025 reaching USD 99.9 million by 2034, 16.14% of global revenue at the start of that period.
Argentina
2nd-largest in Latin America, growing 1.9×.
- In region 2 of 2
- Of region 20%
- Of global 3.2%
- Revenue $10.30M → $20M
3.2% of global revenue is generated in Argentina; USD 10.3 million in 2025, reaching USD 20 million in 2034, and 20% of Latin America.
Middle East and Africa Market Analysis
The 5th-largest region covered — it picks up 0.6 points of share by 2034, while revenue still grows 1.7×.
- Rank 5 of 5
- 2025 share 6.4%
- By 2034 7%
- Revenue $20.40M → $35M
USD 20.4 million of 2025 revenue is generated in Middle East and Africa, 6.36% of the global iprodione market on the way to USD 35 million by 2034. Among the five regions it ranks fifth by revenue in both years.
Share climbs to 7% by 2034, on growth above the market's own 5%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.
Within the region the formulation split tracks the global one; 38% of 2025 revenue in SC, fastest growth of 8.93% in WG. The full report breaks Middle East and Africa out along every axis and by country.
South Africa
The largest market in Middle East and Africa, growing 1.7×.
- In region 1 of 2
- Of region 35%
- Of global 2.2%
- Revenue $7.10M → $12.30M
South Africa is the largest market within Middle East and Africa, generating USD 7.1 million in 2025 and projected to reach USD 12.3 million by 2034. Its 35% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. Regional revenue of USD 20.4 million in 2025 and USD 35 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
South Africa buys along the same lines as the market globally; SC first at 38% of 2025 revenue and 40.01% in 2034, WG fastest at 8.93% on a share moving from 20% to 27.99%. Because the country carries 35% of Middle East and Africa, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-formulation revenue for South Africa appears on its own in the full report.
South Africa regulates iprodione as an agricultural remedy under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, administered by the Registrar of Agricultural Remedies within the Department of Agriculture, Land Reform and Rural Development. A supplier must register the specific formulation before it can be sold, submitting efficacy and safety data covering the crops and pests for which use is claimed. Registration fixes the approved label, including application rates, withholding periods, and hazard warnings that must appear on the container exactly as authorised. Residues on food crops are additionally checked against limits maintained under South African food safety legislation, so a registered use and a compliant label are both needed before produce can legally reach the market.
Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG are the suppliers covered in South Africa. The commercially relevant division is 38% of 2025 revenue in SC, where the volume is, against 8.93% growth in WG, where share moves. The commercial size of that position is USD 20.4 million in 2025 and USD 35 million by 2034, 6.36% of the global total in the base year.
Egypt
2nd-largest in Middle East and Africa, growing 1.7×.
- In region 2 of 2
- Of region 24%
- Of global 1.5%
- Revenue $4.90M → $8.40M
Egypt is sized at USD 4.9 million in 2025, rising to USD 8.4 million by 2034; 1.5% of global revenue and 24% of Middle East and Africa. It is reported separately from South Africa across every segmentation axis in the full report.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by formulation, crop type, application, distribution channel, mode of application, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Suppliers Compete on SC Volume and WG Momentum
The study covers ten suppliers: Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company and Syngenta AG.
The competitive line that matters is the formulation one, not the geographic one. The largest block of revenue is SC: USD 121.6 million in 2025 at 38% of the total, 40.01% in 2034. Incumbency there is expensive to challenge. Share moves in WG, growing 8.93% against 0.25% for EC. Those are different problems, and a supplier strong in one is not thereby strong in the other; that is what sustains a field this size in a USD 320 million market.
Large crop-science groups compete on formulation breadth, regulatory registration coverage across multiple crop labels, and established distributor and retail relationships built over decades, which lets them defend share even as the active ingredient itself has gone off patent. Chinese and Indian generic manufacturers compete mainly on manufacturing scale and delivered price, supplying suspension concentrate and wettable powder formulations into price-sensitive growing regions where brand loyalty matters less than availability and cost. Regional distributors and formulators compete on channel reach and technical support to smallholders, filling gaps that the larger multinational suppliers serve less directly.
Geographic reach is the other axis of competition. Asia Pacific alone accounts for 36.86% of 2025 revenue, so a supplier absent there is absent from the largest part of the market whatever its position elsewhere; Europe adds a further 22.07%.
Per-company profiles, financials, share and development history are in the full report and not here.
List of Key Iprodione Market Companies Profiled
10 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Star Crop Science
- Nulandis(Canada)
- Nanjing Essence Fine-Chemical(China)
- Jiangsu Lanfeng(China)
- Henan Guangnonghuize(China)
- Bayer(Germany)
- Dow AgroSciences(United States)
- BASF SE(Germany)
- Dupont De Nemours & Company(United States)
- Syngenta AG(Switzerland)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Formulation, Crop Type, Application, Distribution Channel, Mode of Application), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 10 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Iprodione Market Size & Projections, 2020–2034, Revenue (USD Million)
Chapter 16.Global Iprodione Market Overview, By Formulation, 2020–2034, Revenue (USD Million)
Chapter 17.Global Iprodione Market Overview, By Crop Type, 2020–2034, Revenue (USD Million)
Chapter 18.Global Iprodione Market Overview, By Application, 2020–2034, Revenue (USD Million)
Chapter 19.Global Iprodione Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Million)
Chapter 20.Global Iprodione Market Overview, By Mode of Application, 2020–2034, Revenue (USD Million)
Chapter 21.Global Iprodione Market Size — Segment Comparison
Chapter 22.Global Iprodione Geography Overview, 2020–2034, Revenue (USD Million)
Chapter 23.North America Iprodione Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 24.Europe Iprodione Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 25.Asia Pacific Iprodione Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 26.Latin America Iprodione Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 27.Middle East and Africa Iprodione Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Formulation
4- 01SC
- 02WP
- 03EC
- 04WG
By Crop Type
2- 01Horticultural
- 02Agricultural
By Application
2- 01Fruits
- 02Vegetables
By Distribution Channel
4- 01Distributors
- 02Agricultural supply stores
- 03Direct sales
- 04Online retailers
By Mode of Application
3- 01Foliar Spray
- 02Soil Treatment
- 03Seed Treatment
Segment categories shown for scope reference. See the Summary tab for revenue share by By Formulation. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
Sizing starts from estimated iprodione production and formulation volumes converted into suspension concentrate, wettable powder, emulsifiable concentrate and water dispersible granule equivalents, then multiplied by realised ex-formulator prices for each formulation and each of the crop and regional channels the product moves through. Volumes are anchored to registered active-ingredient tonnage implied by national crop-protection product registers and by import and export codes covering iprodione technical and formulated goods. That bottom-up build is then checked against the disclosed crop-protection segment revenue of the larger listed suppliers named in this report; where a supplier's disclosed regional revenue implies a different formulation mix than the volume build assumed, the volume or price assumption is corrected rather than the two figures being averaged together.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Interview targets are the commercial and technical roles that actually decide which formulation a grower buys: procurement leads at agricultural distributors and cooperatives, product managers at formulators and generic manufacturers, and regulatory affairs staff who track registration status crop by crop. Retail buyers at agricultural supply stores are included to gauge how quickly online ordering is displacing in-person purchase. Sampling weights Asia Pacific and Latin America more heavily than other regions, reflecting where cultivation area and formulation volume are expanding fastest, while European contacts are drawn specifically from registration and regulatory-affairs functions given the non-renewal pressure iprodione faces there.
Desk research draws on national pesticide registration registers that list iprodione's approved crop uses and any pending non-renewal decisions, the European Union's own pesticide database tracking the active substance's approval status, and customs trade data filed under the harmonized system code covering dicarboximide fungicide formulations. Company-level revenue and segment disclosures from the listed crop-science suppliers are cross-checked against these registers to confirm which formulations remain saleable in which markets. Trade-association benchmarks on formulation mix and channel share for fungicides sold through agricultural distributors and supply stores supplement the volume build where registration data alone does not indicate final product form.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast is built from expected cultivation-area growth for fruit and vegetable crops in the regions where iprodione remains registered, layered against the pace at which the European Union's use restrictions narrow its addressable crop list there. Formulation mix is projected to keep shifting toward water dispersible granules and suspension concentrates as handling and solvent-exposure rules tighten elsewhere, and channel mix is projected to keep shifting toward distributors and online ordering in Asia Pacific. The forecast holds only if no additional major producing country moves to restrict or withdraw the active substance beyond what is already anticipated in Europe.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Outputs are back-tested against recorded formulation-volume and crop-protection revenue growth for the 2020 to 2024 period to confirm the historical build tracks actual reported trends rather than a smoothed trend line. Segment-level shifts, particularly the formulation mix moving toward water dispersible granules and the regional mix moving toward Asia Pacific and Latin America, were reviewed against the same commercial and regulatory contacts interviewed during primary research. Sensitivities were tested around the pace of European Union restriction and around cultivation-area growth in Asia Pacific, since those two assumptions move the forecast total more than any other single input.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
Formulation-level and regional estimates for Asia Pacific and Latin America rest on the firmest ground, where cultivation-area and registration data are current and consistent across sources. The distribution-channel split, particularly the pace of online-retail adoption, is the softest input, since reporting on this shift is thin and uneven across regions. The clearest structural risk is regulatory: a further tightening or an unexpected reversal of the European Union's non-renewal timeline for iprodione would shift both the regional mix and the total more than any single volume or price assumption in this model.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Iprodione Market projected to reach?
USD 499.4 Million by 2034, CAGR 5%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
Asia Pacific leads with 36.86% of global revenue through 2034.
05Which segment leads the market?
SC is the largest line by formulation, at 38% of revenue in 2025.
06Who are the key companies profiled?
Star Crop Science, Nulandis, Nanjing Essence Fine-Chemical, Jiangsu Lanfeng, Henan Guangnonghuize, Bayer, Dow AgroSciences, BASF SE, Dupont De Nemours & Company, Syngenta AG. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.